Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19

Dermatol Ther. 2020 Nov;33(6):e13834. doi: 10.1111/dth.13834. Epub 2020 Jul 8.

Authors

Tyler Enos¹, Haneol S Jeong¹, Travis Vandergriff¹, Heidi T Jacobe¹, Benjamin F Chong¹

Affiliation

¹ Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acute Generalized Exanthematous Pustulosis / diagnosis
Acute Generalized Exanthematous Pustulosis / drug therapy
Acute Generalized Exanthematous Pustulosis / etiology*
Adult
Antiviral Agents / adverse effects*
COVID-19 / diagnosis
COVID-19 Drug Treatment*
Drug Tapering
Female
Glucocorticoids / administration & dosage
Humans
Hydroxychloroquine / adverse effects*
Skin / drug effects*
Skin / pathology
Treatment Outcome

Substances

Antiviral Agents
Glucocorticoids
Hydroxychloroquine